Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of studies focused on microbiome and psoriasis and on microbiome and esophageal cancer from the National Institutes of Health (NIH). The studies being conducted at NYU Langone Medical Center are two of several projects being conducted through the NIH Roadmap for Medical Research as part of the Human Microbiome Project (HMP) taking place at institutions across the country.

Ceragenix Pharmaceuticals, Inc.("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, announced that researchers at National Jewish Health, led by Dr. Donald Y. Leung and Dr. Michael Howell, in collaboration with Dr. Paul B.

Dandruff affects the scalp and causes flakes of skin to appear - it is a common condition. Our skin cells are forever renewing themselves. When the skin cells on our scalp are renewed the old ones are pushed to the surface and out of the scalp. For a person with dandruff the renewal is faster, meaning more dead skin is shed, making the dandruff more noticeable. Dandruff can also occur if the scalp is frequently exposed to extreme temperatures.

Title: Chinese Herb May Treat Autoimmune Diseases
Category: Health News
Created: 6/5/2009
Last Editorial Review: 6/5/2009

Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, has achieved yet another goal by completion of patients' enrollment in its phase II Psoriasis trial. Approximately 70 patients were enrolled to this study, randomized into 4 groups treated with 1, 2 and 4 mg of CF101 and placebo. Patients are taking the drug for 12 weeks plus 2 weeks of follow-up. The trial is being conducted in 10 sites in Israel and Europe.